Koulu M - Search Results

1

Chronic clozapine treatment down-regulates serotonin 5-HT-1c receptors in rat brain.

Hietala J, Koulu M, Kuoppamäki M, Lappalainen J, Syvälahti E. Hietala J, et al. Among authors: koulu m. Prog Neuropsychopharmacol Biol Psychiatry. 1992 Sep;16(5):727-32. doi: 10.1016/0278-5846(92)90028-d. Prog Neuropsychopharmacol Biol Psychiatry. 1992. PMID: 1496128

2

Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.

Lappalainen J, Hietala J, Koulu M, Sjöholm B, Syvälahti E. Lappalainen J, et al. Among authors: koulu m. Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(6):861-72. doi: 10.1016/0278-5846(91)90014-r. Prog Neuropsychopharmacol Biol Psychiatry. 1991. PMID: 1722342

3

Neurochemical effects of chronic co-administration of ritanserin and haloperidol: comparison with clozapine effects.

Lappalainen J, Hietala J, Koulu M, Syvälahti E. Lappalainen J, et al. Among authors: koulu m. Eur J Pharmacol. 1990 Nov 13;190(3):403-7. doi: 10.1016/0014-2999(90)94206-d. Eur J Pharmacol. 1990. PMID: 2125564

4

Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.

Koulu M, Lappalainen J, Hietala J, Sjöholm B. Koulu M, et al. Psychopharmacology (Berl). 1990;101(2):168-71. doi: 10.1007/BF02244121. Psychopharmacology (Berl). 1990. PMID: 2140903

5

Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.

Lappalainen J, Hietala J, Koulu M, Seppälä T, Sjöholm B, Syvälahti E. Lappalainen J, et al. Among authors: koulu m. J Pharmacol Exp Ther. 1990 Feb;252(2):845-52. J Pharmacol Exp Ther. 1990. PMID: 2179533

6

Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.

Koulu M, Lappalainen J, Pesonen U, Hietala J, Syvälahti E. Koulu M, et al. Eur J Pharmacol. 1988 Oct 18;155(3):313-6. doi: 10.1016/0014-2999(88)90521-3. Eur J Pharmacol. 1988. PMID: 3069483

7

5-HT3 receptor antagonist ondansetron does not alter effects of amphetamine on DA metabolism.

Koulu M, Lappalainen J, Hietala J, Sjöholm B, Virtanen R. Koulu M, et al. Neuroreport. 1990 Oct;1(2):126-8. doi: 10.1097/00001756-199010000-00011. Neuroreport. 1990. PMID: 2151795

8

Dopamine D1 receptor antagonism in schizophrenia: is there reduced risk of extrapyramidal side-effects?

Hietala J, Lappalainen J, Koulu M, Syvälahti E. Hietala J, et al. Among authors: koulu m. Trends Pharmacol Sci. 1990 Oct;11(10):406-10. doi: 10.1016/0165-6147(90)90147-z. Trends Pharmacol Sci. 1990. PMID: 2256181 Review.

9

Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.

Koulu M, Sjöholm B, Lappalainen J, Virtanen R. Koulu M, et al. Eur J Pharmacol. 1989 Oct 10;169(2-3):321-4. doi: 10.1016/0014-2999(89)90031-9. Eur J Pharmacol. 1989. PMID: 2530097

10

Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism.

Tiihonen J, Hallikainen T, Lachman H, Saito T, Volavka J, Kauhanen J, Salonen JT, Ryynänen OP, Koulu M, Karvonen MK, Pohjalainen T, Syvälahti E, Hietala J. Tiihonen J, et al. Among authors: koulu m. Mol Psychiatry. 1999 May;4(3):286-9. doi: 10.1038/sj.mp.4000509. Mol Psychiatry. 1999. PMID: 10395222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters